Autor: |
Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana S. Gonzalez-Reiche, Johnstone Tcheou, Ariel Raskin, Dominika Bielak, Sara Morris, Miriam Fried, Temima Yellin, Leeba Sullivan, PARIS study group, Emilia Mia Sordillo, Aubree Gordon, Harm van Bakel, Viviana Simon, Florian Krammer |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024) |
Druh dokumentu: |
article |
ISSN: |
2041-1723 |
DOI: |
10.1038/s41467-024-50052-2 |
Popis: |
Abstract Sero-monitoring provides context to the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and changes in population immunity following vaccine introduction. Here, we describe results of a cross-sectional hospital-based study of anti-spike seroprevalence in New York City (NYC) from February 2020 to July 2022, and a follow-up period from August 2023 to October 2023. Samples from 55,092 individuals, spanning five epidemiological waves were analyzed. Prevalence ratios (PR) were obtained using Poisson regression. Anti-spike antibody levels increased gradually over the first two waves, with a sharp increase during the 3rd wave coinciding with SARS-CoV-2 vaccination in NYC resulting in seroprevalence levels >90% by July 2022. Our data provide insights into the dynamic changes in immunity occurring in a large and diverse metropolitan community faced with a new viral pathogen and reflects the patterns of antibody responses as the pandemic transitions into an endemic stage. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|